Cutaneous side effects are common with many targeted anticancer therapies such as EGFR and VEGF pathway inhibitors. These include acne-like rashes, dry skin, hair changes, and fissures or cracks in the skin. Management of these side effects can allow for continued treatment and better quality of life for patients receiving targeted therapies.
Cutaneous side effects are common with many targeted anticancer therapies such as EGFR and VEGF pathway inhibitors. These include acne-like rashes, dry skin, hair changes, and fissures or cracks in the skin. Management of these side effects can allow for continued treatment and better quality of life for patients receiving targeted therapies.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPT, PDF, TXT or read online from Scribd
Cutaneous side effects are common with many targeted anticancer therapies such as EGFR and VEGF pathway inhibitors. These include acne-like rashes, dry skin, hair changes, and fissures or cracks in the skin. Management of these side effects can allow for continued treatment and better quality of life for patients receiving targeted therapies.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPT, PDF, TXT or read online from Scribd
Synthesis and Biological Activity of 2 - (2 - (7-Chloroquinolin-4-Ylthio) - 4-Methylthiazol-5-Yl) - N-Phenylacetamide Derivatives As Antimalarial and Cytotoxic Agents